Atlas Trials

Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

Clinical trial NCT03267459 · RECRUITING

Trial details

NCT number
NCT03267459
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Status
RECRUITING
Study type
OBSERVATIONAL
Retinoblastoma
Start date
2018-01-11
Primary completion
2028-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.